Orthofix Medical
OFIX
Orthofix Medical (OFIX) news
Recent news
Orthofix sees FY adj. EBITDA $95M to $98M, saw $90M to $93M
Orthofix Medical Inc. (NASDAQ: OFIX) has updated its financial guidance for 2026, projecting non-GAAP adjusted EBITDA in the range of $95 million to $98 million for the full year. This represents a revision from the previous range of $90 million to $93 million. The company attributes the adjustment…
AInvest Wire · Aug 5, 2026Orthofix sees FY net sales $845M to $855M, saw $838M to $848M
AInvest Wire · Aug 5, 2026Orthofix Medical Q2 EPS USD -0.39
AInvest Wire · Aug 5, 2026Orthofix Medical outlook FY adjusted EBITDA USD 95-98 million
AInvest Wire · Aug 5, 2026Orthofix 2Q adj EPS 7.0220c, est. loss/shr 22.750c (2 est.)
AInvest Wire · Aug 5, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.